Cingulate Inc. (CING) vs RenovoRx, Inc. (RNXT)
Cingulate Inc. and RenovoRx, Inc. are both Biotechnology companies. Cingulate Inc. and RenovoRx, Inc. are of similar size ($75.8M and $73.6M). Cingulate Inc. has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Cingulate Inc. leads on 6 and RenovoRx, Inc. on 6.
Valuation
Profitability
| Metric | CING | RNXT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 84.41% | 65.16% |
| Operating margin | 0.00% | (685.22%) | 0.00% |
| Net margin | 0.00% | (621.71%) | 0.00% |
| Free cash flow margin | 0.00% | (604.10%) | 0.00% |
| Return on equity | (198.74%) | (125.23%) | (57.72%) |
| Return on assets | (123.76%) | (97.83%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack